- Author:
Fatemeh ABDI
1
;
Gity OZGOLI
;
Fatemeh Sadat RAHNEMAIE
Author Information
- Publication Type:Clinical Trial
- Keywords: Premenstrual syndrome; Vitamin D; Calcium
- MeSH: Calcium; Case-Control Studies; Checklist; Cross-Sectional Studies; Diet; Epidemiology; Female; Humans; Luteal Phase; Menstrual Cycle; Premenstrual Syndrome; Vitamin D; Vitamins
- From:Obstetrics & Gynecology Science 2019;62(2):73-86
- CountryRepublic of Korea
- Language:English
- Abstract: Premenstrual syndrome (PMS) is a common disorder that affects millions of women of reproductive age worldwide. In recent years, there has been a focus on finding accessible, acceptable, and cost-effective therapeutic approaches with minimal side effects to treat the symptoms of PMS. This systematic review aimed to investigate the role of calcium and vitamin D in Premenstrual syndrome. The PubMed, EMBASE, Web of Science, Scopus, Science Direct, and Google Scholar databases were systematically searched for relevant articles from clinical trial, case-control, and cross-sectional studies. The Strengthening the Reporting of Observational Studies in Epidemiology checklist was used to assess the quality of the selected papers. A total of 28 eligible high-quality papers were reviewed. Low serum levels of calcium and vitamin D during the luteal phase of the menstrual cycle were found to cause or exacerbate the symptoms of PMS. Therefore, the administration of calcium and vitamin D supplements or the use of a diet rich in these two substances can restore serum levels and eliminate or reduce the symptoms of PMS. Calcium and vitamin D supplementation are recommended as an inexpensive, low-risk, acceptable, and accessible approach to eliminate or reduce the symptoms of PMS.